At a glance
- Originator Nonindustrial source
- Class Analgesics; Anti-inflammatories; Antirheumatics; Prostaglandins
- Mechanism of Action Leukotriene inhibitors; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 09 Mar 1999 No-Development-Reported for Rheumatoid arthritis in Ukraine (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Rheumatoid arthritis in Ukraine (Unknown route)